Crewe Advisors LLC reduced its position in The Allstate Co. (NYSE:ALL – Free Report) by 8.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,082 shares of the insurance provider’s stock after selling 200 shares during the period. Crewe Advisors LLC’s holdings in Allstate were worth $401,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. FSA Wealth Management LLC acquired a new position in shares of Allstate during the 3rd quarter worth $26,000. Northwest Investment Counselors LLC purchased a new stake in shares of Allstate in the third quarter valued at about $28,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Allstate in the third quarter valued at approximately $29,000. Peoples Bank KS purchased a new position in shares of Allstate during the 4th quarter worth approximately $49,000. Finally, Transamerica Financial Advisors Inc. acquired a new position in shares of Allstate during the 3rd quarter worth approximately $58,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Price Performance
ALL opened at $192.92 on Thursday. The company has a 50 day moving average of $193.38 and a two-hundred day moving average of $188.81. The Allstate Co. has a 52-week low of $153.87 and a 52-week high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The company has a market cap of $51.09 billion, a P/E ratio of 12.50, a P/E/G ratio of 1.47 and a beta of 0.52.
Allstate Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio is presently 23.83%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. Barclays cut their price target on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. UBS Group upped their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Keefe, Bruyette & Woods lifted their price target on shares of Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Piper Sandler raised their target price on shares of Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 26th. Finally, Bank of America boosted their price target on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $218.13.
View Our Latest Stock Report on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- Which Wall Street Analysts are the Most Accurate?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Where Do I Find 52-Week Highs and Lows?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Use the MarketBeat Stock Screener
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.